Search

Author/Creator Gamalo, M.

1. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. (1st August 2020)

Authors:
Simpson, E.L.; Lacour, J.‐P.; Spelman, L.; Galimberti, R.; Eichenfield, L.F.; Bissonnette, R.; King, B.A.; Thyssen, J.P.; Silverberg, J.I.; Bieber, T.; Kabashima, K.; Tsunemi, Y.; Costanzo, A.; Guttman‐Yassky, E.; Beck, L.A.; Janes, J.M.; DeLozier, A.M.; Gamalo, M.; Brinker, D.R.; Cardillo, T.
Journal:
British journal of dermatology
Issue:
Volume 183:Number 2(2020)
Page Start:
242
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. (5th March 2020)

Authors:
Simpson, E.L.; Lacour, J.‐P.; Spelman, L.; Galimberti, R.; Eichenfield, L.F.; Bissonnette, R.; King, B.A.; Thyssen, J.P.; Silverberg, J.I.; Bieber, T.; Kabashima, K.; Tsunemi, Y.; Costanzo, A.; Guttman‐Yassky, E.; Beck, L.A.; Janes, J.M.; DeLozier, A.M.; Gamalo, M.; Brinker, D.R.; Cardillo, T.
Journal:
British journal of dermatology
Issue:
Volume 183:Number 2(2020)
Page Start:
242
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events. (25th February 2023)

Authors:
Bissonnette, R.; Eichenfield, L. F.; Simpson, E.; Thaçi, D.; Kabashima, K.; Thyssen, J. P.; Guttman‐Yassky, E.; Nunes, F. P.; Gamalo, M.; Ahmad, F.; Kuligowski, M.; Sun, K.; Pipper, C.; Christensen, A. W.; D'Angelo, P.; Milutinovic, M.; Guettner, A.; Silverberg, J. I.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 37:Number 5(2023)
Page Start:
976
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials. (6th October 2020)

Authors:
Bieber, T.; Thyssen, J.P.; Reich, K.; Simpson, E.L.; Katoh, N.; Torrelo, A.; De Bruin‐Weller, M.; Thaci, D.; Bissonnette, R.; Gooderham, M.; Weisman, J.; Nunes, F.; Brinker, D.; Issa, M.; Holzwarth, K.; Gamalo, M.; Riedl, E.; Janes, J.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 35:Number 2(2021)
Page Start:
476
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗